Literature DB >> 6235121

SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions.

R B Mailman, D W Schulz, M H Lewis, L Staples, H Rollema, D L Dehaven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6235121     DOI： 10.1016/0014-2999(84)90044-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  24 in total

1.  D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse.

Authors:  S Cabib; C Castellano; V Cestari; U Filibeck; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.

Authors:  J Lappalainen; J Hietala; E Syvälahti
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.

Authors:  S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.

Authors:  A S Undie; E Friedman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390.

Authors:  M S Kleven; E W Anthony; L I Goldberg; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.

Authors:  J L Nunes; N A Sharif; A D Michel; R L Whiting
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

7.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

8.  S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.

Authors:  H Rollema; M G Feenstra; C J Grol; M H Lewis; L Staples; R B Mailman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

9.  Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.

Authors:  G Serra; M Collu; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.